v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 51,293 $ 55,499
Marketable securities, current 163,794 189,405
Accounts receivable 8,028 3,102
Prepaid expenses and other current assets 9,420 9,761
Total current assets 232,535 257,767
Marketable securities, non-current 19,619 22,359
Property and equipment, net 5,478 5,842
Right-of-use asset 55,886 57,536
Restricted cash 3,443 3,443
Other assets 2,563 2,655
Total assets 319,524 349,602
Current liabilities:    
Accounts payable 683 1,328
Accrued expenses and other current liabilities 12,633 19,363
Deferred revenue, current 21,585 18,712
Operating lease liability, current 5,919 5,774
Total current liabilities 40,820 45,177
Deferred revenue, net of current 25,117 28,457
Operating lease liability, net of current 58,447 59,982
Total liabilities 124,384 133,616
Commitments and contingencies (see Note 11)
Stockholders’ equity:    
Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized, and no shares issued or outstanding as of March 31, 2025 and December 31, 2024, respectively 0 0
Common stock, par value of $0.0001 per share; 150,000,000 shares authorized, and 70,989,661 and 70,625,899 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 7 7
Additional paid-in capital 855,111 849,625
Accumulated other comprehensive income (loss) 43 53
Accumulated deficit (660,021) (633,699)
Total stockholders’ equity 195,140 215,986
Total liabilities and stockholders’ equity $ 319,524 $ 349,602